<DOC>
	<DOCNO>NCT02154308</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity IL-YANG Inactivated Split Influenza Vaccine ( IL-YANG FLU Vaccine Prefilled Syringe INJ . ) administer single intramuscular injection .</brief_summary>
	<brief_title>Phase 3 Study Evaluate Immunogenicity Safety Inactivated Split Influenza Vaccine Healthy Korea Adults</brief_title>
	<detailed_description>This multicenter , open-label study . Subjects provide write informed consent undergo protocol-specific assessment determine eligibility study . Subjects consider eligible assigned appropriate age stratum , give single dose study vaccine . For age stratum , first 142 subject enrol evaluated immunogenicity safety , remain subject subsequently enrol evaluate safety study vaccine . 1 . Group A : healthy adult 18 &lt; 65 year age 2 . Group B : healthy adult ≥ 65 year age The investigator evaluate immunogenicity safety study vaccine throughout study . The immunogenicity assessment perform Visit 1 ( pre-vaccination ) End-of-Study Visit . For safety measurement , subject instruct record adverse event occur vaccination Patient Diary card . Subjects assign immunogenicity safety assessment blood sample drawn antibody titer ( immunogenicity ) testing , afterward , receive 0.5 mL study vaccine intramuscular injection deltoid muscle . Subjects return clinic follow-up visit 4 5 week vaccination , undergo another blood sample antibody titer test . The long-term safety 6 month vaccination also evaluate . Subjects assign safety assessment undergo blood sampling , visit schedule assign immunogenicity safety assessment .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy man woman 18 year age old Woman childbearing potential must negative urine human chorionic gonadotropin ( HCG ) test screen Subject give , fully understood , information study , make voluntary decision , provide write informed consent , participate study comply applicable study requirement . Subject know allergy egg , chicken , neomycin , gentamicin component study vaccine Subject receive influenza vaccine within last 6 month Subject , family history , immune system disorder include immune deficiency disease Subject participate blood donation within 1 week prior vaccination , plan participate blood donation Day 1 Month 7 postvaccination . Subject history GuillainBarre syndrome Subject Down 's syndrome cytogenetic disorder . Subject severe chronic disease investigator 's opinion would make subject good candidate clinical trial Subject hemophilia treat anticoagulant , increased risk serious bleed intramuscular injection Subject acute fever body temperature &gt; 38.0 Cº within 72 hour prior administration study vaccine Subject receive product contain acetylsalicylic acid aspirin within 14 day prior administration study vaccine Subject previously receive another vaccine within 28 day administration study drug , schedule receive another vaccine study period . Subject receive immunosuppressant immune modify drug within last 3 month prior administration study vaccine Subject previously receive immunoglobulin bloodderived product within last 3 month prior administration study vaccine , expect treat immunoglobulin bloodderived product study . Subject participate another experimental study within 30 day prior administration study vaccine Woman childbearing potential screen woman plan become pregnant study . A woman childbearing potential must negative pregnancy test , , unless surgically sterile , must use effective method contraception throughout study eligible study . Periodic abstinence withdrawal consider acceptable method contraception . Use hormonal contraceptive allow . Subject clinically significant medical psychological condition investigator 's opinion would suitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Split influenza vaccine</keyword>
	<keyword>Seasonal influenza vaccine</keyword>
</DOC>